首页> 外文期刊>Journal of Agricultural and Food Chemistry >Role of Pyridoxamine in the Formation of the Amadori/Heyns Compounds and Aggregates during the Glycation of β-Lactoglobulin with Galactose and Tagatose
【24h】

Role of Pyridoxamine in the Formation of the Amadori/Heyns Compounds and Aggregates during the Glycation of β-Lactoglobulin with Galactose and Tagatose

机译:吡rid胺在β-乳球蛋白与半乳糖和塔格糖的糖基化过程中在Amadori / Heyns化合物和聚集体形成中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

The effect of pyridoxamine on the Maillard reaction during the formation of conjugates of β-lactoglobulin with galactose and tagatose under controlled conditions (pH 7, 0.44 a_w, 40 and 50°C, for 6 days) has been studied, for the first time, by means of the changes in reducing carbohydrates, formation of Amadori or Heyns compounds, and aggregates and browning development. The results showed the formation of interaction products between pyridoxamine and galactose or tagatose either in the presence or in the absence of β-lactoglobulin, indicating that pyridoxamine competes with the free amino groups of β-lactoglobulin for the carbonyl group of both carbohydrates. Thus, a small inhibitory effect of pyridoxamine on the initial stages of the Maillard reaction was pointed out. Furthermore, much lower aggregation and color formation rates were observed in the conjugates of β-lactoglobulin galactose/tagatose with pyridoxamine than without this compound, supporting its potent inhibitory effect on the advanced and final stages of the Maillard reaction. These findings reveal the usefulness of food-grade inhibitors of the advanced stages of the Maillard reaction, such as pyridoxamine, that, in combination with mild storage conditions, could lead to the formation of safer neoglycoconjugates without impairing their nutritional quality.
机译:首次研究了吡x胺在受控条件(pH 7、0.44 a_w,40和50°C,6天)下β-乳球蛋白与半乳糖和塔格糖共轭物形成过程中对美拉德反应的影响,通过减少碳水化合物的变化,形成Amadori或Heyns化合物以及聚集和褐变的发展。结果显示,在存在或不存在β-乳球蛋白的情况下,吡ido胺和半乳糖或塔格糖之间形成相互作用产物,表明吡pyr胺与β-乳球蛋白的游离氨基竞争两种碳水化合物的羰基。因此,指出了吡ido胺对美拉德反应初始阶段的小抑制作用。此外,在β-乳球蛋白半乳糖/塔格糖与吡ido胺的共轭物中观察到比没有该化合物低得多的聚集和颜色形成速率,支持了其对美拉德反应的晚期阶段的有效抑制作用。这些发现揭示了美拉德反应晚期食品级抑制剂(如吡ido胺)的有用性,与温和的储存条件相结合,可导致形成更安全的新糖结合物而不损害其营养质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号